NRx Pharmaceuticals, Inc.

📍 Wilmington, United States🗓 Founded 2015👥 19 employees💰 Last funded 2021
Biotechnology Research🌐 nrxpharma.com
Website LinkedIn
NRx Pharmaceuticals, Inc. draws upon decades of collective, scientific, and drug-development experience to address very high unmet needs of patients and bring improved health to patients. The U.S. Food and Drug Administration (“FDA”) has additionally granted Breakthrough Therapy designation, a Special Protocol Agreement, and a Biomarker Letter of Support for NRX-101, an investigational medicine for the treatment of severe bipolar depression in patients with acute suicidal ideation and behavior (ASIB) after initial stabilization with ketamine or other effective therapy. NRx Pharmaceuticals is led by executives who have held leadership roles at Lilly, Pfizer, and Novartis as well as major investment banking institutions.
3
Total investors
2
Early stage
0
Mid stage
1
Late stage
2015
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
Hong Kong SAR
1
Investor activity2015–2021 · investors recorded per year
201512017120211
Recent (last 2y)Earlier
Frequently asked questions
Who invested in NRx Pharmaceuticals, Inc.?
NRx Pharmaceuticals, Inc. has 3 investors on record on gritt.io, including 2 early-stage backers and 1 late-stage investors.
When did NRx Pharmaceuticals, Inc. last raise funding?
The most recent investment in NRx Pharmaceuticals, Inc. recorded on gritt.io was in 2021.
When was NRx Pharmaceuticals, Inc. founded?
NRx Pharmaceuticals, Inc. was founded in 2015.
What industry is NRx Pharmaceuticals, Inc. in?
NRx Pharmaceuticals, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is NRx Pharmaceuticals, Inc. based?
NRx Pharmaceuticals, Inc. is headquartered in Wilmington, United States.